• -
43 Results
Vaccine
Scientific Misconceptions and Myths Perpetuated in the 2017 Texas Legislative Session
By Kirstin R.W. Matthews and Melody T. Tan Vaccines and vaccine exemptions are increasingly contentious issues in Texas. In this issue brief, the authors dispel five common misconceptions about vaccines that were presented during public hearings at the Texas House of Representatives in 2017.
Melody Tan, Kirstin R.W. Matthews October 23, 2018
A woman receives a vaccine in her left arm.
Medical Freedom, Privacy, and Fear of Discrimination: The 2017 Texas Legislative Session Anti-vaccine Arguments
In this brief, the authors analyze transcripts from public hearrings at the Texas legislature to identify key arguments against school-mandated vaccinations. To ensure public health, policymakers and other stakeholders should be well informed about vaccines, the impact of vaccine-preventable disease, and the risks associated with putting absolute individual rights above public health concerns, they conclude.
Kirstin R.W. Matthews, Melody Tan October 22, 2018
A digitized version of North America.
Latin America Initiative | Issue Brief
Emerging Latin American Multinational Firms: Outward Foreign Direct Investment in the Pacific Alliance Countries
The landscape is changing for foreign direct investment in Latin America. Investments flow not only from north to south, but also from south to south and south to north. What's more, relatively small firms in developing countries are becoming as likely as multinationals to invest abroad.
Roberto Echandi, Yago Aranda, Daniela Gomez-Altamirano June 27, 2017
A woman receives a vaccine in her left arm.
How Too Much Freedom of Choice Endangers Public Health: The Effect of Nonmedical Exemptions From School-entry Vaccinations in Texas
This policy brief analyzes the impact of the increasing number of parents who opt their children out of school-entry vaccinations for nonmedical reasons in Texas and argues that the state should make obtaining nonmedical exemptions more rigorous in order to reduce the public health risks and costs associated with vaccine-preventable diseases.
Jackie Olive, Kirstin R.W. Matthews October 13, 2016